(Q33704191)

28 July 2017

1 reference

title

Does neurotensin mediate the effects of antipsychotic drugs? (English)

1 reference

28 July 2017

Kinkead B

1

1 reference

28 July 2017

Binder EB

series ordinal

2

1 reference

28 July 2017

Nemeroff CB

series ordinal

3

1 reference

28 July 2017

language of work or name

English

0 references

publication date

1 August 1999

1 reference

28 July 2017

published in

Biological Psychiatry

1 reference

28 July 2017

volume

46

1 reference

28 July 2017

issue

3

1 reference

28 July 2017

page(s)

340-351

1 reference

Repeated administration of the neurotensin receptor antagonist SR 48692 differentially regulates mesocortical and mesolimbic dopaminergic systems.

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900070-0

Vesicular and cytoplasmic localization of neurotensin-like immunoreactivity (NTLI) in neurons postsynaptic to terminals containing NTLI and/or tyrosine hydroxylase in the rat central nucleus of the amygdala

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900070-0

Alterations in regional brain concentrations of neurotensin and bombesin in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900070-0

Hypothermia and intolerance to cold induced by intracisternal administration of the hypothalamic peptide neurotensin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900070-0

Effects of neurotensin on dopamine release and metabolism in the rat striatum and nucleus accumbens: cross-validation using in vivo voltammetry and microdialysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900070-0

Pharmacological evidence for common mechanisms underlying the effects of neurotensin and neuroleptics on in vivo dopamine efflux in the rat nucleus accumbens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900070-0

Haloperidol but not clozapine increases neurotensin receptor mRNA levels in rat substantia nigra

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900070-0

Cellular distribution of neurotensin receptors in rat brain: immunohistochemical study using an antipeptide antibody against the cloned high affinity receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900070-0

CSF concentrations of neurotensin in schizophrenia: an investigation of clinical and biochemical correlates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900070-0

Mesencephalic dopaminergic neurons in primary cultures express functional neurotensin receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900070-0

Blockade of neurotensin receptor by SR 48692 potentiates the facilitatory effect of haloperidol on the evoked in vivo dopamine release in the rat nucleus accumbens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900070-0

Molecular cloning of a levocabastine-sensitive neurotensin binding site

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900070-0

Neurotensin increases extracellular striatal dopamine levels in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900070-0

Regionally specific effects of atypical antipsychotic drugs on striatal Fos expression: The nucleus accumbens shell as a locus of antipsychotic action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900070-0

Opposing roles for dopamine D2 and D3 receptors on neurotensin mRNA expression in nucleus accumbens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900070-0

Autoradiographic localization of mu-opioid and neurotensin receptors within the mesolimbic dopamine system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900070-0

Effects of neurotensin on regional brain concentrations of dopamine, serotonin and their main metabolites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900070-0

The nonpeptide neurotensin antagonist, SR 48692, used as a tool to reveal putative neurotensin receptor subtypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900070-0

Effects of antipsychotic drugs on latent inhibition: sensitivity and specificity of an animal behavioral model of clinical drug action.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900070-0

Neurotensin in human brain: regional distribution and effects of neurological illness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900070-0

Neurotensin blocks certain amphetamine-induced behaviours

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900070-0

Further indication that distinct dopaminergic subsets project to the rat cerebral cortex: lack of colocalization with neurotensin in the superficial dopaminergic fields of the anterior cingulate, motor, retrosplenial and visual cortices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900070-0

The effects of intra-accumbens neurotensin on sensorimotor gating

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900070-0

Pro-dopamine effects of neurotensin on sensorimotor gating deficits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900070-0

The striatal neurotensin receptor modulates striatal and pallidal glutamate and GABA release: functional evidence for a pallidal glutamate-GABA interaction via the pallidal-subthalamic nucleus loop.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900070-0

Relation of CSF neurotensin concentrations to symptoms and drug response of psychotic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900070-0

Neurotensin innervation of the human cerebral cortex: lack of colocalization with catecholamines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900070-0

Dopamine-cell depolarization block as a model for the therapeutic actions of antipsychotic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900070-0

The modulation of corticoaccumbens transmission by limbic afferents and dopamine: a model for the pathophysiology of schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900070-0

Dopaminergic control of 125I-labeled neurotensin binding site density in corticolimbic structures of the rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900070-0

Occurrence of neurotensinlike immunoreactivity in subpopulations of hypothalamic, mesencephalic, and medullary catecholamine neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900070-0

Differential effect of haloperidol on release of neurotensin in extrapyramidal and limbic systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900070-0

Neurotensin: topographical distribution in rat brain by immunohistochemistry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900070-0

Neurotensin and the serotonergic system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900070-0

Neurotensin affects hyperactivity but not stereotypy induced by pre and post synaptic dopaminergic stimulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900070-0

Serotonin, dopamine and their interactions in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900070-0

Effect of acute and daily neurotensin and enkephalin treatments on extracellular dopamine in the nucleus accumbens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900070-0

Neurotensin neurons in the ventral tegmental area project to the medial nucleus accumbens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900070-0

Serotonin-dopamine interaction and its relevance to schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900070-0

Differential effects of antipsychotic drugs on the neurotensin concentration of discrete rat brain nuclei

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900070-0

Neurotensin and cholecystokinin microinjected into the ventral tegmental area modulate microdialysate concentrations of dopamine and metabolites in the posterior nucleus accumbens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900070-0

Anatomy and Mechanisms of Neurotensin‐Dopamine Interactions in the Central Nervous System

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900070-0

Expression of the D3 dopamine receptor in peptidergic neurons of the nucleus accumbens: comparison with the D1 and D2 dopamine receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900070-0

Postpubertal emergence of hyperresponsiveness to stress and to amphetamine after neonatal excitotoxic hippocampal damage: a potential animal model of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900070-0

Latent inhibition: the effect of nonreinforced pre-exposure to the conditional stimulus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900070-0

The effect of neurotensin on food consumption in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900070-0

The effects of neuropeptides on discrete-trial conditioned avoidance responding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900070-0

Neurotensin in the human brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900070-0

The 100-kDa neurotensin receptor is gp95/sortilin, a non-G-protein-coupled receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900070-0

Differential effects of haloperidol and clozapine on neurotensin gene transcription in rat neostriatum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900070-0

Distribution of neurotensin binding sites in rat brain: a light microscopic radioautographic study using monoiodo [125I]Tyr3-neurotensin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900070-0

Pharmacological specificity of the increase in neurotensin concentrations after antipsychotic drug treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900070-0

Neurotensin: central nervous system effects of a hypothalamic peptide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900070-0

Neurotensin-like immunoreactivity in cerebrospinal fluid of patients with schizophrenia, depression, anorexia nervosa-bulimia, and premenstrual syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900070-0

Regional Brain Concentrations of Neuropeptides in Huntington's Chorea and Schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900070-0

Neurotensin receptor expression in the rat forebrain and midbrain: a combined analysis by in situ hybridization and receptor autoradiography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900070-0

Differential expression of neurotensin receptor mRNA in the dopaminergic cell groups of the rat diencephalon and mesencephalon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900070-0

Centrally administered neurotensin: activity in the Julou-Courvoisier muscle relaxation test in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900070-0

Neurotensin receptors are located on dopamine-containing neurones in rat midbrain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900070-0

The nucleus accumbens as a complex of functionally distinct neuronal ensembles: an integration of behavioural, electrophysiological and anatomical data.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900070-0

Distribution of neurotensin receptors in mammalian brain. What it is telling us about its interactions with other neurotransmitter systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900070-0

Neurotensin receptor binding sites in monkey and human brain: autoradiographic distribution and effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900070-0

Effects of short- and long-term haloperidol administration and withdrawal on regional brain cholecystokinin and neurotensin concentrations in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900070-0

Atypical antipsychotic drugs selectively increase neurotensin efflux in dopamine terminal regions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900070-0

Neurotensin causes a greater increase in the metabolism of dopamine in the accumbens than in the striatum in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900070-0

Peptides, the limbic lobe and schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900070-0

Distribution of neuropeptides in the limbic system of the rat: the amygdaloid complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900070-0

Characterization and autoradiographic distribution of neurotensin binding sites in the human brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900070-0

A subpopulation of dopaminergic neurons in rat ventral mesencephalon contains both neurotensin and cholecystokinin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900070-0

Neurotensin and cholecystokinin coexistence within neurons of the ventral mesencephalon: projections to forebrain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900070-0

CSF neurotensin concentrations and antipsychotic treatment in schizophrenia and schizoaffective disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900070-0

Possible neuronal mechanisms involved in neurotensin-induced catalepsy in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900070-0

Neurotensin induces catalepsy in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900070-0

Effects of neurotensin in a rodent model of tardive dyskinesia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900070-0

The neurotensin antagonist SR 48692 fails to modify the behavioural responses to a dopamine D1 receptor agonist in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900070-0

The electrophysiological actions of neurotensin in the central nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900070-0

Extensive co-localization of neurotensin with dopamine in rat meso-cortico-frontal dopaminergic neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900070-0

Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900070-0

Using an animal model of deficient sensorimotor gating to study the pathophysiology and new treatments of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900070-0

Correspondence between high affinity 125I-neurotensin binding sites and dopaminergic neurons in the rat substantia nigra and ventral tegmental area: a combined radioautographic and immunohistochemical light microscopic study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900070-0

Distribution of 125I-neurotensin binding sites in human forebrain: comparison with the localization of acetylcholinesterase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900070-0

Structure and functional expression of the cloned rat neurotensin receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900070-0

Facilitation of GABA release by neurotensin is associated with a reduction of dopamine release in rat nucleus accumbens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900070-0

Distribution of neurotensin and its receptor in the central nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900070-0

Chronic neuroleptic treatment enhances neurotensin receptor binding in human and rat substantia nigra

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900070-0

Neurotensin Decreases the Affinity of Dopamine D2Agonist Binding by a G Protein-Independent Mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900070-0

Cortical maldevelopment, anti-psychotic drugs, and schizophrenia: a search for common ground

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900070-0

The switching model of latent inhibition: an update of neural substrates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900070-0

Autoradiographic characterization of neurotensin receptors in the entorhinal cortex of schizophrenic patients and control subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900070-0

Neurotensin terminals form synapses primarily with neurons lacking detectable tyrosine hydroxylase immunoreactivity in the rat substantia nigra and ventral tegmental area

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900070-0

Electrophysiological responses of neurones in the nucleus accumbens to hippocampal stimulation and the attenuation of the excitatory responses by the mesolimbic dopaminergic system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900070-0

Neurotensin-immunoreactive neurons in the ventral striatum of the adult rat: ventromedial caudate-putamen, nucleus accumbens and olfactory tubercle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900070-0

On the significance of subterritories in the "accumbens" part of the rat ventral striatum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900070-0

Neuropeptides in the amygdala of controls, schizophrenics and patients suffering from Huntington's chorea: an immunohistochemical study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900070-0

10.1016/S0006-3223(99)00070-0

7 January 2021

Identifiers

DOI

1 reference

28 July 2017

1 reference